- Home
- RSSS vs IKNA Comparison
RSSS vs IKNA Comparison
Compare RSSS & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- IKNA
- Stock Information
- Founded
- RSSS 2006
- IKNA 2016
- Country
- RSSS United States
- IKNA United States
- Employees
- RSSS N/A
- IKNA N/A
- Industry
- RSSS Business Services
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- IKNA Health Care
- Exchange
- RSSS Nasdaq
- IKNA Nasdaq
- Market Cap
- RSSS 86.4M
- IKNA 80.8M
- IPO Year
- RSSS N/A
- IKNA 2021
- Fundamental
- Price
- RSSS $3.08
- IKNA $1.73
- Analyst Decision
- RSSS Strong Buy
- IKNA Buy
- Analyst Count
- RSSS 1
- IKNA 2
- Target Price
- RSSS $6.00
- IKNA $3.00
- AVG Volume (30 Days)
- RSSS 61.1K
- IKNA 58.7K
- Earning Date
- RSSS 11-14-2024
- IKNA 11-07-2024
- Dividend Yield
- RSSS N/A
- IKNA N/A
- EPS Growth
- RSSS N/A
- IKNA N/A
- EPS
- RSSS N/A
- IKNA N/A
- Revenue
- RSSS $46,607,410.00
- IKNA $659,000.00
- Revenue This Year
- RSSS $13.84
- IKNA N/A
- Revenue Next Year
- RSSS $10.24
- IKNA N/A
- P/E Ratio
- RSSS N/A
- IKNA N/A
- Revenue Growth
- RSSS 19.26
- IKNA N/A
- 52 Week Low
- RSSS $2.21
- IKNA $1.22
- 52 Week High
- RSSS $3.50
- IKNA $2.32
- Technical
- Relative Strength Index (RSI)
- RSSS 71.77
- IKNA 54.06
- Support Level
- RSSS $2.81
- IKNA $1.71
- Resistance Level
- RSSS $3.16
- IKNA $1.72
- Average True Range (ATR)
- RSSS 0.13
- IKNA 0.05
- MACD
- RSSS 0.04
- IKNA -0.00
- Stochastic Oscillator
- RSSS 86.89
- IKNA 53.85
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.